期刊文献+

免疫因子与间质性膀胱炎/膀胱疼痛综合征相关性研究 被引量:2

On Role of Immune Factors in Occurrence and Progression of Interstitial Cystitis/Bladder Pain Syndrome
下载PDF
导出
摘要 目的探讨免疫因子在间质性膀胱炎/膀胱疼痛综合征发生与进展中的作用.方法选取间质性膀胱炎/膀胱疼痛综合征患者42例为观察组,同期行输尿管镜检查的18例患者正常膀胱组织为对照组.透射电子显微镜观察浆细胞和肥大细胞的表达;免疫组化法检测白细胞介素(IL)-2,IL-10,Siglec-15的表达水平;进行盆腔疼痛和尿频、尿急症状(PUF)评分,分析免疫因子表达与PUF评分的关系.结果观察组42例间质性膀胱炎/膀胱疼痛综合征患者中36例在透射电子显微镜下观察可见浆细胞和肥大细胞,其中肥大细胞出现脱颗粒状态26例;对照组膀胱黏膜组织中透射电子显微镜下未见浆细胞和肥大细胞.观察组患者膀胱黏膜组织中IL-2,IL-10呈弱阳性、强阳性表达的比例明显高于对照组,IL-2,IL-10呈阴性表达的比例明显低于对照组,差异具有统计学意义(P<0.01);膀胱黏膜组织中Siglec-15表达情况在两组间差异无统计学意义(P>0.05).观察组IL-2,IL-10强阳性患者的PUF评分明显高于弱阳性和阴性患者,差异具有统计学意义(P<0.01);Siglec-15阴性患者的PUF评分明显低于阳性和强阳性患者,差异具有统计学意义(P<0.01).结论间质性膀胱炎/膀胱疼痛综合征患者膀胱黏膜组织中存在浆细胞浸润、肥大细胞出现脱颗粒;IL-2,IL-10表达水平与症状程度呈正相关,Siglec-15表达水平与症状程度呈负相关. Objective To investigate the role of immune factors in the occurrence and progression of interstitial cystitis/bladder pain syndrome.Method 42 patients with interstitial cystitis/bladder pain syndrome were selected as the observation group,while18 patients with normal bladder tissue underwent ureteroscopic examination during the same period were selected as the control group.The expression of plasma cells and mast cells were observed by transmission electron microscopy,the expression levels of interleukin (IL)-2,IL-10 and Siglec-15 were detected by immunohistochemistry,pelvic pain,frequency of urination and urinary emergencies (PUF) were scored,and the relationship between the expression of immune factors and PUF score was analyzed. Results In the observation group,36 cases of 42 patients with interstitial cystitis/bladder pain syndrome were observed under transmission electron microscopy ,of which26 cases had degranulation of mast cells,while in the control group,no plasma cells and mast cells were observed under transmission electron microscopy.The proportion of weak positive and strong positive expression of IL-2 and IL-10 in bladder mucosa of the observation group was significantly higher than that of the control group,and the proportion of negative expression of IL-2 and IL-10 was significantly lower than that of the control group ( P <0.01 );there was no significant difference in the expression of Siglec-15 in bladder mucosa between the two groups ( P >0.05 ).The PUF scores of the patients with strong positive IL-2 and IL-10 in the observation group were significantly higher than those of the patients with weak positive and negative IL-10 ( P <0.01);PUF scores of the patients with negative Siglec-15 were significantly lower than those of the patients with strong positive IL-2 and IL-10 ( P <0. 01). ConclusionThere are plasma cell infiltration and mast cell degranulation in bladder mucosa of patients with interstitial cystitis/bladder pain syndrome.The expression levels of IL-2 and IL-10 are positively correlated with the degree of symptoms,while the expression levels of Siglec-15 are negatively correlated with the degree of symptoms.
作者 杨安卿 夏宇 Yang Anqing;Xia Yu(Luwan Branch,Ruijin Hospital Affiliated Medical College of Shanghai Jioatong University,Shanghai 200025,China;Ruijin Hospital Affiliated Medical College of Shanghai Jioatong University,Shanghai 200025,China)
出处 《北华大学学报(自然科学版)》 CAS 2019年第4期468-471,共4页 Journal of Beihua University(Natural Science)
基金 上海市科学技术委员会科研计划项目(14411950403)
关键词 间质性膀胱炎/膀胱疼痛综合征 免疫因子 肥大细胞 浆细胞 interstitial cystitis/bladder pain syndrome immunefactors mast cells plasma cells
  • 相关文献

参考文献10

二级参考文献47

  • 1宋伟,赵勇,王慕文,李连军,曲华伟,崔子连.琥珀酸索利那新治疗膀胱肿瘤选择性光汽化术后膀胱痉挛的疗效观察[J].泌尿外科杂志(电子版),2013,5(4):19-21. 被引量:3
  • 2周峰,汪超军,刘犇,罗金旦,郑祥毅,黄啸,金百冶.经尿道等离子电切术治疗女性腺性膀胱炎(附97例报告)[J].微创泌尿外科杂志,2014,3(4):227-229. 被引量:5
  • 3张潍平,孙宁,黄澄如,田军,谢向辉,宋宏程.尿道下裂手术方法选择再认识[J].临床儿科杂志,2004,22(6):347-349. 被引量:22
  • 4吕坚伟,薛蔚,冷静.碱化利多卡因联合肝素膀胱灌注治疗膀胱疼痛综合征/间质性膀胱炎215例报告[J].中华泌尿外科杂志,2008,29(1):54-56.
  • 5HANNO P, DMOCHOWSKI R. Status of international consen sus on interstitial cystitisbladder pain syndrome/ painful blad- der syndrome: 2008 snapshot[J]. Neurourol Urodyn, 2009, 28 (4) :274-286.
  • 6HANNO PM, ERICKSON D, MOLDW1N R, et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUAGuidelineAmendment[J]. J Urol, 2015, 193(5):1545- 1553.
  • 7PEEKER R, FALL M. Toward a precise definition of interstitial cystitisfurther evidence of differences in classic and nonulcer disease[J]. J Urol, 2002, 167(6):2470- 2472.
  • 8HANNO P, LIN A, NORDLING J, et al. Bladder pain syn drome committee of the international consultation on inconti- nence[J]. Neurourol Urodyn, 2010, 29(1):191-198.
  • 9PHILIP M. HANNO. Bladder pain syndrome (interstitial cysti- tis) and related disorders[M]//I WEIN AJ, KAVOUSSI LR, NOVICK AC, et al. Campbell Walsh Urology. 10th ed. Phila- delphia, PAElsevier Saunders,2011:357-401.
  • 10GII.IENWATER JY, WEIN AJ. Summary of the national insti tute of arthritis, diabetes, digestive and kidney diseases work- shop on interstitial cystitis, national institutes of health, Bethes- da, Maryland, August 28-29, 1987[J]. J Urol, 1988,140(1): 203-206.

共引文献44

同被引文献28

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部